The implications of positive peritoneal lavage cytology in potentially resectable pancreatic cancer

World Journal of Surgery

Volumn 36, Issue 9, 2012, Pages 2187-2191

  Yoshioka, Ryuji ^a   Saiura, Akio ^a   Koga, Rintaro ^a   Arita, Junichi ^a   Takemura, Nobuyuki ^a   Ono, Yoshihiro ^a   Yamamoto, Junji ^b   Yamaguchi, Toshiharu ^a  

^a CANCER INSTITUTE HOSPITAL   (Japan)

^b NATIONAL DEFENSE MEDICAL COLLEGE HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CYTODIAGNOSIS; FEMALE; HUMAN; MALE; METASTASIS; MIDDLE AGED; MORTALITY; PANCREAS TUMOR; PATHOLOGY; PERITONEUM LAVAGE; PERITONEUM TUMOR; RETROSPECTIVE STUDY; SURVIVAL; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CYTODIAGNOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PERITONEAL LAVAGE; PERITONEAL NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84867860883     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-012-1622-0     Document Type: Article

References (21)

1. Siegel R, Ward E, Brawley O, Jemal A (2011) Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61: 212-236
2. Gillen S, Schuster T, Meyer Zum Buschenfelde C et al (2010) Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages. PLoS Med 7:e1000267
3. Aletti GD, Gallenberg MM, Cliby WA et al (2007) Current management strategies for ovarian cancer. Mayo Clin Proc 82:751-770
4. Japanese Gastric Cancer Association (2011) Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 14:101-112
5. American Joint Committee on Cancer (2010) Exocrine and endocrine pancreas. In: The AJCC Cancer Staging Manual, 7th ed. Springer, New York, pp 241-249
6. Clark CJ, Traverso LW (2010) Positive peritoneal lavage cytology is a predictor of worse survival in locally advanced pancreatic cancer. Am J Surg 199:657-662
7. Fernandez-del Castillo C, Rattner DW, Warshaw AL (1995) Further experience with laparoscopy and peritoneal cytology in the staging of pancreatic cancer. Br J Surg 82:1127-1129
8. Jimenez RE, Warshaw AL, Fernandez-Del Castillo C (2000) Laparoscopy and peritoneal cytology in the staging of pancreatic cancer. J Hepatobiliary Pancreat Surg 7:15-20
9. Leach SD, Rose JA, Lowy AM et al (1995) Significance of peritoneal cytology in patients with potentially resectable adenocarcinoma of the pancreatic head. Surgery 118:472-478
10. Makary MA, Warshaw AL, Centeno BA et al (1998) Implications of peritoneal cytology for pancreatic cancer management. Arch Surg 133:361-365
11. Merchant NB, Conlon KC, Saigo P et al (1999) Positive peritoneal cytology predicts unresectability of pancreatic adenocarcinoma. J Am Coll Surg 188:421-426
12. Meszoely IM, Lee JS, Watson JC et al (2004) Peritoneal cytology in patients with potentially resectable adenocarcinoma of the pancreas. Am Surg 70:208-213 discussion 213-204
13. Nakao A, Fujii T, Sugimoto H et al (2006) Oncological problems in pancreatic cancer surgery. World J Gastroenterol 12: 4466-4472
14. Warshaw AL (1991) Implications of peritoneal cytology for staging of early pancreatic cancer. Am J Surg 161:26-29 discussion 29-30
15. Yachida S, Fukushima N, Sakamoto M et al (2002) Implications of peritoneal washing cytology in patients with potentially resectable pancreatic cancer. Br J Surg 89:573-578
16. Yamada S, Takeda S, Fujii T et al (2007) Clinical implications of peritoneal cytology in potentially resectable pancreatic cancer: positive peritoneal cytology may not confer an adverse prognosis. Ann Surg 246:254-258
17. Ueno H, Kosuge T, Matsuyama Y et al (2009) A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer. Br J Cancer 101:908-915
18. Tempero MA, Arnoletti JP, Behrman S et al (2010) Pancreatic adenocarcinoma. J Natl Compr Cancer Netw 8:972-1017
19. Ferrone CR, Haas B, Tang L et al (2006) The influence of positive peritoneal cytology on survival in patients with pancreatic adenocarcinoma. J Gastrointest Surg 10:1347-1353
20. Conroy T, Desseigne F, Ychou M et al (2011) FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 364:1817-1825
21. Katz MH, Pisters PW, Evans DB et al (2008) Borderline resectable pancreatic cancer: the importance of this emerging stage of disease. J Am Coll Surg 206:833-846 discussion 846-838